The Automation Conversation: What Pharma and Flow Cores Can Learn from Each Other​

What happens when pharma and flow cores face the same challenge — doing more with less?​

Join Ryan Duggan (AbbVie) and David Leclerc (President, GLIIFCA) for a balanced discussion on how automation is reshaping modern flow cytometryworkflows.​

Ryan will share insights from AbbVie’s first experience using the C-FREE™ Pluto HT system, where automation delivered improved sample consistency and stronger cell recovery while reducing manual variability. David will reflect on how the GLIIFCA community is engaging with automation — exploring how core laboratories can integrate new tools to improve reproducibility, manage workloads, and make better use of shared resources.​

This 30-minute panel is designed for flow cytometrists, core facility directors, and translational researchers who are exploring practical ways to introduce automation into real-world workflows.

Learning Objectives:

• Building confidence in data quality and sample integrity through reproducible automation.

• Enhancing reproducibility across users and sites through standardized, centrifuge-less workflows. ​

• Expanding accessibility and affordability of automation from entry-level labs to enterprise-scaleenvironments.​

• Explore how scientific collaboration between pharma and core facilities candrive the next step in flow cytometry innovation —rethinking sample preparation from centrifugation to collaboration.​